Bacterial Skin and Skin Structure Infections
📧 Sign up to get email alerts when something new happens for Bacterial Skin and Skin Structure Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018) [Phase 3]
A Phase 3 pediatric trial evaluating Tedizolid Phosphate (MK-1986) versus a comparator for acute bacterial skin and skin structure infection…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients [Phase 4]
Phase 4 clinical trial update on a strategy to prevent drug-induced nephrotoxicity in high-risk patients; the study was terminated with resu…
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: Hospital Avoidance Strategies for ABSSSI [Phase 4]
Phase 4 clinical trial evaluating hospital avoidance strategies for acute bacterial skin and skin structure infections (ABSSSI) has been ter…
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI) [Phase 3]
Phase 3 trial comparing levonadifloxacin (IV and oral) to linezolid (IV and oral) for acute bacterial skin and skin structure infections has…
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections [Phase 3]
Phase 3 clinical trial update for ceftobiprole in acute bacterial skin and skin structure infections has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) [Phase 4]
Phase 4 clinical trial evaluating a new pathway for treating acute bacterial skin and skin structure infections has completed with results p…
-
CLINICAL_TRIALS trial_result · 2019-04-19Clinical Trial Update: Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections [Phase 3]
Phase 3 trial comparing oral sodium fusidate (CEM-102) to oral linezolid for acute bacterial skin and skin structure infections has complete…
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections [Phase 3]
Phase 3 trial comparing single-dose versus two-dose dalbavancin regimens for acute bacterial skin and skin structure infections completed wi…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 [Phase 3]
Phase 3 study REVIVE-2 comparing iclaprim to vancomycin for acute bacterial skin and skin structure infections has completed with results po…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 [Phase 3]
A Phase 3 trial (REVIVE-1) comparing iclaprim to vancomycin for acute bacterial skin and skin structure infections has completed with result…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections [Phase 3]
Phase 3 trial results compare delafloxacin with standard therapy (vancomycin plus aztreonam) for acute bacterial skin and skin structure inf…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections [Phase 3]
Phase 3 trial comparing delafloxacin to vancomycin plus aztreonam for acute bacterial skin and skin structure infections has completed with …
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA [Phase 4]
Phase 4 study evaluating the clinical and economic outcomes of ceftaroline fosamil for acute bacterial skin and skin structure infections as…
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections. [Phase 3]
Phase 3 trial comparing TR-701 (tidarubicin? actually TR-701 is dalbavancin-like? Not sure) for acute bacterial skin and skin structure infe…
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections [Phase 3]
Phase 3 trial results show dalbavancin was effective and safe for acute bacterial skin and skin structure infections; the study completed wi…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of dalbavancin for acute bacterial skin and skin structure infections, including absc…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci [Phase 2]
This Phase 2 trial tested AFN-12520000 for acute bacterial skin and skin structure infections due to Staphylococci and has completed, report…
-
CLINICAL_TRIALS trial_result · 2010-03-18Clinical Trial Update: Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) [Phase 2]
This clinical trial update reports the completion of a Phase 2 study comparing NXL103 to Linezolid for acute bacterial skin and skin structu…